Stanford Hospitals & Clinics Announces Plans for New Outpatient Cancer Center in South Bay Region

STANFORD, Calif. January 28, 2013 —Stanford Hospital & Clinics today announced plans for a new outpatient cancer center, to be located at the intersection of State Route 85 (SR85) and Los Gatos Boulevard in San Jose, California. The existing 70,000 square foot facility will offer the latest in cancer care, along with other complementary practices. The center is expected to open in 2015 with patient care provided by physicians from Stanford and the local medical community.

The new outpatient facility will support the latest advances in cancer treatments, including access to clinical trials and Stanford's National Cancer Institute-designated cancer center. "As an oncologist, I am excited about the opportunity to significantly expand patient access to Stanford's cancer care and our nationally recognized quality programs," said Douglas W. Blayney, MD, Medical Director of the Stanford Cancer Center. "When it opens, this new outpatient center will offer patients coordinated medical services which are integrated with those they could receive by traveling to the Stanford campus, all in one convenient South Bay setting."

The four-story facility will be Stanford's most comprehensive outpatient medical facility outside of Stanford Hospital & Clinics in Palo Alto, and the Stanford Medicine Outpatient Center in Redwood City.

"We're extremely pleased to be able to provide residents of the South Bay region with convenient access to Stanford's leading edge, patient-centered care," said Amir Dan Rubin, President & CEO, Stanford Hospital & Clinics. "Stanford is home to some of the most important innovations in cancer treatment, including the first use of the linear accelerator, which is the basis for today's radiation therapy, as well as development of the CyberKnife®, a robotic radiosurgery tool which provides a whole new way to treat certain kinds of tumors. With more than 300 ongoing clinical trials in cancer and pioneering work underway in genomics to develop targeted therapies, Stanford is helping lead the fight against this challenging disease."

About the Stanford Cancer Institute

The Stanford Cancer Institute (SCI) is one of only two National Cancer Institute–designated Cancer Centers in the region. Committed to giving patients every clinical and technological advantage in the prevention and treatment of cancer, the SCI leverages the expertise of more than 300 physicians and researchers working together to unravel cancer's secrets. Stanford's scientific focus includes cancer cell and stem cell biology, immunology, molecular imaging and genetics. Translational medicine is the cornerstone of Stanford's cancer treatment programs, combining new advances with compassionate care and supportive services. Stanford is also one of the founding members of the National Comprehensive Cancer Network (NCCN), an alliance of 21 of the world's leading cancer centers dedicated to improving the quality and effectiveness of care provided to patients with cancer. Stanford is consistently recognized as one of the top hospitals in America for cancer care according to US News & World Report. For more information, visit the Stanford Cancer Institute.